Stifel analyst Andreas Heine downgraded EMS-Chemie to Hold from Buy with a price target of CHF 700, down from CHF 810. The analyst expects a weak Q4 amid destocking and sees a lack of catalysts for the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue